Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
KBIO COMPANY Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩267.00 |
52 Week High | ₩591.00 |
52 Week Low | ₩225.00 |
Beta | -0.15 |
1 Month Change | -16.82% |
3 Month Change | 13.14% |
1 Year Change | -46.60% |
3 Year Change | -80.00% |
5 Year Change | -91.75% |
Change since IPO | -99.72% |
Recent News & Updates
Shareholder Returns
A038530 | KR Semiconductor | KR Market | |
---|---|---|---|
7D | 0% | -5.8% | -0.4% |
1Y | -46.6% | 69.5% | 4.5% |
Return vs Industry: A038530 underperformed the KR Semiconductor industry which returned 69.5% over the past year.
Return vs Market: A038530 underperformed the KR Market which returned 4.5% over the past year.
Price Volatility
A038530 volatility | |
---|---|
A038530 Average Weekly Movement | 12.8% |
Semiconductor Industry Average Movement | 7.9% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.8% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A038530's share price has been volatile over the past 3 months.
Volatility Over Time: A038530's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 36 | Jong-Ju Lee | www.gold-pacific.com |
KBIO COMPANY Inc. engages in the bio distribution business. The company supplies experimental equipment and various reagents to general hospitals, universities, research institutes, etc.; and engages in distribution, bidding, equipment rental, and other business. It serves through online and offline stores.
KBIO COMPANY Inc. Fundamentals Summary
A038530 fundamental statistics | |
---|---|
Market cap | ₩30.84b |
Earnings (TTM) | -₩11.82b |
Revenue (TTM) | ₩27.32b |
1.1x
P/S Ratio-2.6x
P/E RatioIs A038530 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A038530 income statement (TTM) | |
---|---|
Revenue | ₩27.32b |
Cost of Revenue | ₩23.73b |
Gross Profit | ₩3.59b |
Other Expenses | ₩15.41b |
Earnings | -₩11.82b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -102.32 |
Gross Margin | 13.16% |
Net Profit Margin | -43.25% |
Debt/Equity Ratio | 0% |
How did A038530 perform over the long term?
See historical performance and comparison